Salim I. Khakoo
Tremona Road
Southampton, ENG, United Kingdom
Southampton, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A.
Journal: Clinical and experimental immunology
Published: November 07, 2025
Modeling the response to interleukin-21 to inform natural killer cell immunotherapy.
Journal: Immunology and cell biology
Published: August 15, 2025
Enhancing natural killer cell anti-tumour activity through macrophage manipulation.
Journal: Frontiers in immunology
Published: June 30, 2025
Characterisation of People Living With Chronic Hepatitis B Virus Infection in England and Stratification by HBsAg Levels: A Cross-Sectional Study.
Journal: Journal of viral hepatitis
Published: May 29, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis.
Journal: Immunotherapy advances
Published: April 25, 2025
Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines.
Journal: Journal of viral hepatitis
Published: April 03, 2025
Modulation of anti-tumour immunity by XPO1 inhibitors.
Journal: Exploration of targeted anti-tumor therapy
Published: January 13, 2025
Modeling the response to interleukin-21 to inform natural killer cell immunotherapy.
Journal: Immunology and cell biology
Published: November 04, 2024
Idiosyncratic acute liver failure induced by Tirzepatide.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: October 30, 2024
The nuclear export protein XPO1 provides a peptide ligand for natural killer cells.
Journal: Science advances
Published: August 23, 2024
NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity.
Journal: Biomedicines
Published: June 12, 2024
Last Updated: 09/26/2026